Pliant Therapeutics Inc Ordinary Shares PLRX
News
Pliant Therapeutics Announces Presentation of PLN-101095 Preclinical and Clinical Data at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer
Pliant Therapeutics Announces Presentations at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer
Pliant Therapeutics Appoints Craig Blanchette, Ph.D., as Senior Vice President, Research (siRNA)
Pliant Therapeutics Announces Upcoming Presentation at European Society for Medical Oncology Congress 2026
Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer
